Beta Bionics

Beta Bionics, Inc. announced that it plans to release its fourth quarter and full year 2024 financial results after the financial markets close on Tuesday, March 25, 2025. Management will host a conference call and concurrent webcast on the same day at 4:30 pm ET (1:30 pm PT), to review the company’s fourth quarter and full year 2024 performance. ? The link to the webcast will be available on website in the “Investors—Events & Presentations” section or at?https://bit.ly/4iFSCWn ? For more information:?https://bit.ly/4idPPDX

We invite you to join us on March 20 for an insightful Association of Diabetes Care & Education Specialists hosted webinar exploring the latest advancements in automated insulin delivery (AID) and the evolving role of the Diabetes Care and Education Specialist (DCES) in supporting iLet users. Sign up: https://bit.ly/41KcL6G This session, sponsored by Beta Bionics, will cover:? ??Recent innovations in AID technology with the iLet Bionic Pancreas and its adaptive closed-loop algorithms? ??How these advancements are shaping clinical practices? ??The expanding role of the DCES in optimizing patient outcomes? ??Overview of the results of the pivotal trial and the most recent real-world data analysis? ??Discussion of the impact of technological advancements on clinical practice and the DCES's evolving role in supporting iLet users? ??The benefits of focusing on behavioral education rather than prescriptive therapy adjustments This webinar will begin at 1:00 pm Eastern / 12:00 pm Central / 11:00 am Mountain / 10:00 am Pacific. Safety info: https://lnkd.in/gTSbdT3R

This week, Beta Bionics made its IPO debut, marking an incredible milestone in our journey to redefine diabetes management. ? Our CEO, Sean Saint, joined OJ Renick on Schwab Network to share what makes Beta Bionics and the iLet Bionic Pancreas a game-changer in insulin delivery. ? Again, we want to extend huge thank you to our team, our partners, and the diabetes community for making this moment possible. The future of bionic diabetes management starts now. Watch the full interview here:????https://bit.ly/3ExgsEK

? 80% of people with diabetes live with uncontrolled blood glucose and are at risk from complications. Beta Bionics is working to change that. ?? We’re so excited $BBNX is now #NasdaqListed! Catch the recap of their big day. ??

?? From a child’s diabetes diagnosis to becoming #NasdaqListed: what a journey for Beta Bionics! ?? Proud to be your exchange partner as you continue to make diabetes easier for everyone, every day.

Sean Saint, CEO of Beta Bionics, shares his remarks on IPO day. We’re thrilled to welcome you to the #NasdaqListed family, $BBNX! ??

Today is a significant day in Beta Bionic's history as we formally go public. Our message is lighting up Times Square today, and this milestone truly represents the dreams and hard work that led to this accomplishment. ? ?Our team at Beta Bionics is thrilled to begin this new chapter, as it will create even more opportunities for us to serve, expand, and make a greater impact on the future of diabetes management. ? ?? We would like to thank our partners, healthcare providers, Bionic Universe members, and everyone who has followed our journey. This is only the beginning – here's to reaching even more milestones and transforming diabetes management.

It's an exciting day at Beta Bionics! $BBNX

Beta Bionics [BBNX] Rings the Nasdaq Opening Bell.

What if managing Type 1 diabetes felt less like a chore and more like second nature? ? That’s exactly what Dakota found after switching to the iLet Bionic Pancreas. In his interview with the Juicebox Podcast?episode, he shared how the iLet simplified his diabetes management and gave him more time and freedom to focus on what matters most. ? Hear his inspiring journey on this episode of?The Juicebox Podcast:?https://lnkd.in/gdnfvzFe